MetaCap

Akso Health Group Financial Ratios

NASDAQ: AHGConsumer DiscretionaryBusiness ServicesUSD

1.25+0.11 (+9.65%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Akso Health Group ratio analysis

Akso Health Group earned a net margin of -135.0% in FY 2026, up from -913.4% a year earlier. Gross margin was -0.1% compared with a median of 10.1% over the prior 9 years. Return on equity reached -10.3%, meaning Akso Health Group generated -0.10 dollars of profit for every dollar of shareholders' equity.

At the end of FY 2026, AHG traded at 222.0 times earnings; across the 5 fiscal years shown, its year-end P/E ranged from 6.1 to 222.0, with a median of 24.8. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Akso Health Group financial ratios (annual)

Akso Health Group annual financial ratios
RatioFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
P/E ratio (at fiscal year end)222.006.0616.57————100.2024.77—
Price / sales347.9856.0867.991.8516.1051.488.04132.0414.23—
Price / book26.604.161.192.797.865.231.163.8610.90—
Gross margin-0.1%-1.9%5.1%9.6%10.1%100.0%100.0%-100.2%100.0%100.0%
Operating margin-149.7%-1,125.4%-357.8%-108.2%-54.3%-241.7%-695.7%-194.6%70.7%43.3%
Net margin-135.0%-913.4%-391.8%-10.3%-280.9%-1,984.5%-1,029.7%149.7%61.1%37.4%
Free cash flow margin-92.5%6.9%56.0%-24.7%-143.9%573.2%-845.7%-47.1%81.4%34.5%
Return on equity (ROE)-10.3%-67.8%-6.8%-15.6%-137.2%-201.6%-148.0%4.4%46.8%36.5%
Return on assets (ROA)-9.8%-62.8%-6.7%-6.6%-26.8%-109.9%-88.5%3.2%40.0%30.2%
Debt / equity——————0.420.16——
Current ratio21.7714.2039.521.761.242.094.213.686.84—
Revenue growth-6.4%512.1%-81.7%119.7%241.9%-74.6%87.1%-96.6%368.0%—
EPS growth-93.8%128.6%————-1,560.0%-92.7%585.0%150.0%

Related